NRA-Quetiapine XR: Some lots exceed the intake limit of N-nitroso-desalkyl-quetiapine (NDAQ)
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: NRA-Quetiapine XR
Issue: Health products - Product quality
What to do: Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Distribution: National
Audience: General public, Healthcare, Industry
Recall class: Type II
We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.
Get health product recall alertsCA$3.99/mo · cancel anytime
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|
| NORA PHARMA INC | NRA-Quetiapine XR | DIN 02510677 | Tablet (Extended-Release) | QUETIAPINE FUMARATE 50mg | M2216571 & M2214003 |
Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NDAQ)